InMed Pharmaceuticals announces completed enrollment in phase 1 clinical trial of INM-755 CBN Cream in healthy subjects

InMed Pharmaceuticals announces completed enrollment in phase 1 clinical trial of INM-755 CBN Cream in healthy subjects. (Credit: PublicDomainPictures from Pixabay)